SEC Form 4 · accession 0001238705-26-000007
INTENSITY THERAPEUTICS, INC. · INTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Bender
Officer — President and CEO · Director
Period of report
Jul 16, 2026
Accepted (ET)
Jul 20, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001567264
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F1 | $4.90 | Jul 16, 2026 | A | 78,000 | A | Jul 16, 2026 | Jul 16, 2036 | Common Stock | 78,000 | 78,000 | D |
Explanation of responses
- F1This option will vest, subject to the individual's continued service with Intensity Therapeutics, Inc., in four, equal, annual installments, beginning on July 16, 2026.